UK Research and Innovation's science funding cuts have drawn attention to the closure of Jodrell Bank, but a less visible yet equally vital facility is also under threat: the world's most intense source of pulsed muons at the Rutherford Appleton Laboratory. This was highlighted in a letter to the Guardian from Prof Stephen Blundell of Oxford, who emphasized the facility's importance for fundamental research.
Muon Facility Under Threat
Muons are subatomic particles used to investigate magnetism, superconductivity, battery materials, and other areas of scientific and societal importance. UK scientists have been at the forefront of developing these techniques, but the unique facility now faces closure due to the cuts, according to Blundell.
The commentary has largely focused on the iconic Lovell telescope at Jodrell Bank, described as a "source of wonder and pride" in previous correspondence, but Blundell argues that the muon source is equally important and its potential loss is less visible.
AI-Designed Bacteriophages: Promise Over Fear
In a separate letter, Peter Forbes from Muswell Hill, London, responded to a Guardian article about safety fears over AI-designed viruses. He criticized editors for reaching for the "fear" button when something promising for human medicine is in prospect.
Forbes clarified that the viruses in question are bacteriophages, which are natural enemies of bacteria, have been used in medicine for over 100 years, and already combat disease-resistant bacteria. Engineering bacteriophages to create a truly effective treatment for general use has been ongoing in many labs for decades.
He argued that if there is one task AI ought to be employed in above all others, it is this. The letter reflects a broader concern about balanced reporting on scientific advancements, particularly those involving AI.
Broader Implications
The letters come amid ongoing debates over science funding and the ethical use of AI in medicine. The closure of the muon facility would represent a significant loss to UK science, while the potential of AI-designed phages offers hope for tackling antibiotic resistance.
Both writers call for a more nuanced public discourse, urging recognition of the value of such research and the need for measured reporting on emerging technologies.
